Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis
US6858587B2 · kind B2 · utility
10Cited by
2References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 1, 2002 |
| Grant date | Feb 22, 2005 |
| Priority date | — |
| Expiry date | Nov 1, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/4846
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to use of FVII and/or FVIIa and/or another TF agonist and/or FVIIai and/or another TF antagonist in therapeutic treatment of pathological conditions increased or decreased cell apoptosis is required.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.